Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors (Q38079160)

28 August 2017

1 reference

title

Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors (English)

1 reference

28 August 2017

1 reference

1

Alkomiet Hasan

1 reference

28 August 2017

Amanda Mitchell

2

1 reference

28 August 2017

Anja Schneider

series ordinal

3

1 reference

28 August 2017

Tobias Halene

series ordinal

4

1 reference

28 August 2017

Schahram Akbarian

series ordinal

5

1 reference

28 August 2017

5 February 2013

1 reference

28 August 2017

12

1 reference

European Archives of Psychiatry and Clinical Neuroscience

inferred from page(s)

published in

1 reference

28 August 2017

263

1 reference

28 August 2017

273-284

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-013-0395-2

28 August 2017

0 references

cites work

Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase inhibitors: a new perspective for the treatment of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Antineoplastic chemotherapy induced QTc prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

HDAC1 regulates fear extinction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Amygdalocortical circuitry in schizophrenia: from circuits to molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The complex language of chromatin regulation during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Spatial memory consolidation is associated with induction of several lysine-acetyltransferase (histone acetyltransferase) expression levels and H2B/H4 acetylation-dependent transcriptional events in the rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Quetiapine for bipolar depression: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

'The missing genes: what happened to the heritability of psychiatric disorders?'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin replication and epigenome maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Circadian regulator CLOCK is a histone acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The human histone H3 complement anno 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The pharmaceutical potential of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Targeting the correct HDAC(s) to treat cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The treatment of cognitive impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

An epigenetic blockade of cognitive functions in the neurodegenerating brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Reelin promoter hypermethylation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

HDAC2 negatively regulates memory formation and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Epigenetic GABAergic targets in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

PDE inhibitors in psychiatry--future options for dementia, depression and schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Extinction memory is impaired in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Clinical and experimental applications of sodium phenylbutyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Schizophrenia: treatment targets beyond monoamine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Creating zinc monkey wrenches in the treatment of epigenetic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

CBP histone acetyltransferase activity is a critical component of memory consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Linking molecules to mood: new insight into the biology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Cortical inhibitory neurons and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin higher-order structures and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Chromatin looping and the probability of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The role of HDACs inhibitors in childhood and adolescence acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

HDAC3 is a critical negative regulator of long-term memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

HDAC3 and the molecular brake pad hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Neurocognition in first-episode schizophrenia: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Epigenomic profiling reveals DNA-methylation changes associated with major psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Epigenetic alterations are critical for fear memory consolidation and synaptic plasticity in the lateral amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

High content analysis of histone acetylation in human cells and tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Altered histone acetylation is associated with age-dependent memory impairment in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Perinatal nicotine exposure induces asthma in second generation offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Cancer epigenetics reaches mainstream oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The epigenetic bottleneck of neurodegenerative and psychiatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Schizophrenia as a disorder of disconnectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone fold modifications control nucleosome unwrapping and disassembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

The personal impact of schizophrenia in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

A transcription factor-binding domain of the coactivator CBP is essential for long-term memory and the expression of specific target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Evidence that clozapine directly interacts on the GABAB receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Valproate administration to mice increases histone acetylation and 5-lipoxygenase content in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Charting histone modifications and the functional organization of mammalian genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

Is it possible to be schizophrenic yet neuropsychologically normal?

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00406-013-0395-2

21 January 2018

12 December 2020

Microarray analysis of postmortem temporal cortex from patients with schizophrenia

1 reference

12 December 2020

Practice guideline for the treatment of patients with schizophrenia, second edition.

1 reference

12 December 2020

Management of bipolar disorder

1 reference

12 December 2020

Understanding transgenerational epigenetic inheritance via the gametes in mammals

1 reference

12 December 2020

Glutamate receptor expression in schizophrenic brain

1 reference

12 December 2020

Cognitive deficits as treatment targets in schizophrenia

1 reference

12 December 2020

Micronucleated erythrocytes as an index of cytogenetic damage in humans: demographic and dietary factors associated with micronucleated erythrocytes in splenectomized subjects

1 reference

12 December 2020

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

12 December 2020

Epilepsy, antiepileptic drugs (AEDs) and cognition.

1 reference

12 December 2020

Cognitive deficits and psychiatric rehabilitation outcomes in schizophrenia

1 reference

12 December 2020

Distinctive chromatin in human sperm packages genes for embryo development

1 reference

12 December 2020

The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach

1 reference

12 December 2020

Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation

1 reference

12 December 2020

QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature

1 reference

12 December 2020

Histone deacetylase inhibitors: a novel target of anticancer therapy (review).

1 reference

12 December 2020

Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases

1 reference

12 December 2020

10.1007/S00406-013-0395-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference